Rajesh Somashekhar Naranapura

Rajesh Somashekhar Naranapura

Active Director Director DIN 05258021
DIN 05258021 First appointment Nov 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Nov 2017
Shareholding value •••• Premium profile

About Rajesh Somashekhar Naranapura

Data last updated:

Rajesh Somashekhar Naranapura is a Director at Wrizto Healthcare Private Limited (since 2020) and Director at Wenzins Technologies (India) Private Limited (since 2020). The companies operate in Healthcare, Business Services and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹83.5 Lakh; the largest is Wrizto Healthcare Private Limited at ₹64.6 Lakh (FY 2025). Earlier, Rajesh Somashekhar Naranapura was an Additional Director at Symlux Solutions Private Limited (2017–2019) and Director at Brainisle Technology Solutionz Private Limited (2019–2022).

DIN 05258021
Primary Designation Director
Industry Healthcare
First Appointment 18 Nov 2017
Oldest Company Age 13 yrs
Largest company Wrizto Healthcare Private Limited · ₹64.6 Lakh (FY 2025)
Combined revenue ₹83.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wrizto Healthcare Private Limited U72900KA2017PTC100371
Director07 Sep 20202017₹64.6 Lakh (FY 2025)Active
Director07 Sep 20202013₹18.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Symlux Solutions Private Limited U74999MH2017PTC289430
Additional Director18 Nov 20172017Active
Director27 Jun 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wenzins Technologies (India) Private Limited
Wrizto Healthcare Private Limited
Symlux Solutions Private Limited
Brainisle Technology Solutionz Private Limited
Premium access

Shareholding and investment profile for Rajesh Somashekhar Naranapura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Somashekhar Naranapura

Rajesh Somashekhar Naranapura currently holds 2 directorships: Wrizto Healthcare Private Limited (Director, since 07 Sep 2020, revenue ₹64.6 Lakh (FY 2025)); Wenzins Technologies (India) Private Limited (Director, since 07 Sep 2020, revenue ₹18.9 Lakh (FY 2025)).

Rajesh Somashekhar Naranapura was first appointed on 18 Nov 2017 as Additional Director at Symlux Solutions Private Limited. The most recent appointment on record is 07 Sep 2020 at Wenzins Technologies (India) Private Limited.

The 2 current companies of Rajesh Somashekhar Naranapura that report revenue have a combined latest revenue of ₹83.5 Lakh: Wrizto Healthcare Private Limited ₹64.6 Lakh (FY 2025); Wenzins Technologies (India) Private Limited ₹18.9 Lakh (FY 2025).

Rajesh Somashekhar Naranapura held 2 earlier board appointments: Symlux Solutions Private Limited (Additional Director, 18 Nov 2017 to 05 Dec 2019); Brainisle Technology Solutionz Private Limited (Director, 27 Jun 2019 to 18 Aug 2022).

The current boards of Rajesh Somashekhar Naranapura's companies include Anantha Murthy Manohar (Wrizto Healthcare Private Limited), Aradhana Katke (Wrizto Healthcare Private Limited), Manish Katke (Wrizto Healthcare Private Limited), Ramaswamy Balasubramanian (Wrizto Healthcare Private Limited), Sanjay Kumar Sai (Wrizto Healthcare Private Limited), Varma Dileep (Wrizto Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available